By Elizabeth Murphy, Manager of Business Development, LSN
Service Provider Showcase participant, Amarex Clinical Research joined Digital RESI on June 8-10 by hosting a dynamic workshop on Expediting U.S. FDA Submissions/Trial Initiations and Acceptance of Foreign Data by the U.S. FDA. The Amarex team put on a well-attended workshop helping early-stage entrepreneurs navigate the often-complicated processes working with the FDA. Of their experience with Digital RESI, the team said, “This virtual conference provided Amarex a fantastic opportunity to present in front of leading venture capitalists and pharma/biotech startups on top strategies to get products through the FDA clinical trials approval process. “
As a sponsor of the event, Amarex’s content received prominent placement on the 3-day event agenda, but also the partnering platform. Newcomers to the Digital RESI experience, the Amarex team said, “RESI’s platform provides the life sciences industry with innovative ways to network through their partnering program, allowing our team members to build new relationships with key executives. We look forward to participating in future RESI events.”
Digital RESI returns in September, as a part of RESI Partnering Week, alongside RESI AI and RESI Longevity. Learn more about the 5-day partnering experience and how your organization can take part in the sponsorship opportunities, reach more clients, and help them reach their goals.
| For a demo, or to see how many investors in our a database are interested in your product, feel free to schedule a time that works best for you via LSN BD team’s Calendly link below. | |||
| International & MA (USA) | West Coast (USA) | East Coast (USA) & Canada | Midwest (USA) |
 |
 |
 |
 |
| Greg Mannix Vice President International Business Development Schedule a call with me! |
Candice He Global Investment Strategist Schedule a call with me! |
Elizabeth Murphy Manager of Business Development Schedule a call with me! |
Antoinette Lowre Manager of Business Development Schedule a call with me! |
Next Phase Newsletter 
Leave a comment